{"id":1099309,"date":"2021-05-05T12:18:06","date_gmt":"2021-05-05T10:18:06","guid":{"rendered":"https:\/\/frezzapartners.com\/?p=1099309"},"modified":"2021-05-05T12:18:41","modified_gmt":"2021-05-05T10:18:41","slug":"oncologia-relay-therapeutics-accoglie-un-ex-manager-astrazeneca","status":"publish","type":"post","link":"https:\/\/frezzapartners.com\/en\/oncologia-relay-therapeutics-accoglie-un-ex-manager-astrazeneca\/","title":{"rendered":"Oncologia, in Relay Therapeutics arriva un ex manager AstraZeneca"},"content":{"rendered":"<p>photo by Chokniti Khongchum<\/p>\n<pre id=\"tw-target-text\" class=\"tw-data-text tw-text-large XcVN5d tw-ta\" dir=\"ltr\" data-placeholder=\"Traduzione\"><span class=\"Y2IQFc\" lang=\"it\">\u00a0<\/span><\/pre>\n<p>Il mese scorso Twitter aveva rivelato, che Charles Fert\u00e9, M.D., Ph.D. di AstraZeneca, direttore senior e capo progetto globale di ricerca e sviluppo in oncologia, stava lasciando la Big Pharma, senza sapere quale sarebbe stata la sua nuova destinazione.<\/p>\n<p><a href=\"https:\/\/www.fiercebiotech.com\/biotech\/astrazeneca-s-cancer-r-d-exec-charles-ferte-joins-relay-to-run-its-lead-asset-as-another\">Ora lo sappiamo<\/a>, ed \u00e8 una storia che si \u00e8 gi\u00e0 verificata spesso in passato: un manager che lascia una grande societ\u00e0 globale per il mondo della &#8220;scienza grezza&#8221; delle biotecnologie. Per essere precisi, Fert\u00e9 sta prendendo il testimone alla <a href=\"https:\/\/relaytx.com\/\">Relay Therapeutics<\/a> come Vice President e guida per RLY-4008, un inibitore selettivo e orale di piccole molecole di FGFR2, un recettore tirosin chinasi che \u00e8 spesso alterato in alcuni tipi di cancro.<\/p>\n<p>Ha lasciato AstraZeneca poco dopo la scomparsa del suo responsabile della ricerca sul cancro Jose Baselga, a causa di una malattia cerebrale molto rara e fatale. Negli ultimi tempi l&#8217;azienda farmaceutica britannica \u00e8 stata sotto il microscopio per il suo vaccino COVID-19, ma sono ormai diversi anniche la societ\u00e0 sta spingendo per diventare non un player di vaccini ma un leader internazionale in area oncologia.<\/p>\n<p>In Relay, dunque, Fert\u00e9 si concentrer\u00e0 su RLY-4008, che ha recentemente avviato il suo primo test clinico e ha i dati iniziali previsti entro la fine dell&#8217;anno. &#8220;Entusiasta di entrare a far parte di [Relay]!&#8221;, Ha detto Fert\u00e9 su Twitter. &#8220;Mi sento privilegiato di far parte di questo eccellente team e di poter portare farmaci differenziati ai pazienti con il cancro&#8221;.<\/p>\n<pre id=\"tw-target-text\" class=\"tw-data-text tw-text-large XcVN5d tw-ta\" dir=\"ltr\" data-placeholder=\"Traduzione\"><span class=\"Y2IQFc\" lang=\"it\">\u00a0<\/span><\/pre>\n","protected":false},"excerpt":{"rendered":"<p>photo by Chokniti Khongchum \u00a0 Il mese scorso Twitter aveva rivelato, che Charles Fert\u00e9, M.D., Ph.D. di AstraZeneca, direttore senior e capo progetto globale di ricerca e sviluppo in oncologia, stava lasciando la Big Pharma, senza sapere quale sarebbe stata la sua nuova destinazione. Ora lo sappiamo, ed \u00e8 una storia che si \u00e8 gi\u00e0 verificata spesso in passato: un manager che lascia una grande societ\u00e0 globale per il mondo della &#8220;scienza grezza&#8221; delle biotecnologie. Per essere precisi, Fert\u00e9 sta&#8230;<\/p>\n","protected":false},"author":297440,"featured_media":1099310,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[141],"tags":[2711,3154],"class_list":["post-1099309","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-astrazeneca","tag-relay-therapeutics"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Oncologia, in Relay Therapeutics arriva un ex manager AstraZeneca - Frezza Partners<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/frezzapartners.com\/oncologia-relay-therapeutics-accoglie-un-ex-manager-astrazeneca\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Oncologia, in Relay Therapeutics arriva un ex manager AstraZeneca - Frezza Partners\" \/>\n<meta property=\"og:description\" content=\"photo by Chokniti Khongchum \u00a0 Il mese scorso Twitter aveva rivelato, che Charles Fert\u00e9, M.D., Ph.D. di AstraZeneca, direttore senior e capo progetto globale di ricerca e sviluppo in oncologia, stava lasciando la Big Pharma, senza sapere quale sarebbe stata la sua nuova destinazione. Ora lo sappiamo, ed \u00e8 una storia che si \u00e8 gi\u00e0 verificata spesso in passato: un manager che lascia una grande societ\u00e0 globale per il mondo della &#8220;scienza grezza&#8221; delle biotecnologie. Per essere precisi, Fert\u00e9 sta...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/frezzapartners.com\/oncologia-relay-therapeutics-accoglie-un-ex-manager-astrazeneca\/\" \/>\n<meta property=\"og:site_name\" content=\"Frezza Partners\" \/>\n<meta property=\"article:published_time\" content=\"2021-05-05T10:18:06+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-05-05T10:18:41+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/frezzapartners.com\/wp-content\/uploads\/2021\/05\/pexels-chokniti-khongchum-3082451-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1709\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Frezza Partners\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Frezza Partners\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/oncologia-relay-therapeutics-accoglie-un-ex-manager-astrazeneca\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/oncologia-relay-therapeutics-accoglie-un-ex-manager-astrazeneca\\\/\"},\"author\":{\"name\":\"Frezza Partners\",\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/#\\\/schema\\\/person\\\/b953d1492c9f06a9923aed3b3cbe9fc0\"},\"headline\":\"Oncologia, in Relay Therapeutics arriva un ex manager AstraZeneca\",\"datePublished\":\"2021-05-05T10:18:06+00:00\",\"dateModified\":\"2021-05-05T10:18:41+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/oncologia-relay-therapeutics-accoglie-un-ex-manager-astrazeneca\\\/\"},\"wordCount\":250,\"image\":{\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/oncologia-relay-therapeutics-accoglie-un-ex-manager-astrazeneca\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/frezzapartners.com\\\/wp-content\\\/uploads\\\/2021\\\/05\\\/pexels-chokniti-khongchum-3082451-scaled.jpg\",\"keywords\":[\"astrazeneca\",\"relay therapeutics\"],\"articleSection\":[\"News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/oncologia-relay-therapeutics-accoglie-un-ex-manager-astrazeneca\\\/\",\"url\":\"https:\\\/\\\/frezzapartners.com\\\/oncologia-relay-therapeutics-accoglie-un-ex-manager-astrazeneca\\\/\",\"name\":\"Oncologia, in Relay Therapeutics arriva un ex manager AstraZeneca - Frezza Partners\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/oncologia-relay-therapeutics-accoglie-un-ex-manager-astrazeneca\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/oncologia-relay-therapeutics-accoglie-un-ex-manager-astrazeneca\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/frezzapartners.com\\\/wp-content\\\/uploads\\\/2021\\\/05\\\/pexels-chokniti-khongchum-3082451-scaled.jpg\",\"datePublished\":\"2021-05-05T10:18:06+00:00\",\"dateModified\":\"2021-05-05T10:18:41+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/#\\\/schema\\\/person\\\/b953d1492c9f06a9923aed3b3cbe9fc0\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/oncologia-relay-therapeutics-accoglie-un-ex-manager-astrazeneca\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/frezzapartners.com\\\/oncologia-relay-therapeutics-accoglie-un-ex-manager-astrazeneca\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/oncologia-relay-therapeutics-accoglie-un-ex-manager-astrazeneca\\\/#primaryimage\",\"url\":\"https:\\\/\\\/frezzapartners.com\\\/wp-content\\\/uploads\\\/2021\\\/05\\\/pexels-chokniti-khongchum-3082451-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/frezzapartners.com\\\/wp-content\\\/uploads\\\/2021\\\/05\\\/pexels-chokniti-khongchum-3082451-scaled.jpg\",\"width\":2560,\"height\":1709},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/oncologia-relay-therapeutics-accoglie-un-ex-manager-astrazeneca\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/frezzapartners.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Oncologia, in Relay Therapeutics arriva un ex manager AstraZeneca\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/#website\",\"url\":\"https:\\\/\\\/frezzapartners.com\\\/\",\"name\":\"Frezza Partners\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/frezzapartners.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/#\\\/schema\\\/person\\\/b953d1492c9f06a9923aed3b3cbe9fc0\",\"name\":\"Frezza Partners\",\"url\":\"https:\\\/\\\/frezzapartners.com\\\/en\\\/author\\\/fr3zz4partn3rs\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Oncologia, in Relay Therapeutics arriva un ex manager AstraZeneca - Frezza Partners","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/frezzapartners.com\/oncologia-relay-therapeutics-accoglie-un-ex-manager-astrazeneca\/","og_locale":"en_US","og_type":"article","og_title":"Oncologia, in Relay Therapeutics arriva un ex manager AstraZeneca - Frezza Partners","og_description":"photo by Chokniti Khongchum \u00a0 Il mese scorso Twitter aveva rivelato, che Charles Fert\u00e9, M.D., Ph.D. di AstraZeneca, direttore senior e capo progetto globale di ricerca e sviluppo in oncologia, stava lasciando la Big Pharma, senza sapere quale sarebbe stata la sua nuova destinazione. Ora lo sappiamo, ed \u00e8 una storia che si \u00e8 gi\u00e0 verificata spesso in passato: un manager che lascia una grande societ\u00e0 globale per il mondo della &#8220;scienza grezza&#8221; delle biotecnologie. Per essere precisi, Fert\u00e9 sta...","og_url":"https:\/\/frezzapartners.com\/oncologia-relay-therapeutics-accoglie-un-ex-manager-astrazeneca\/","og_site_name":"Frezza Partners","article_published_time":"2021-05-05T10:18:06+00:00","article_modified_time":"2021-05-05T10:18:41+00:00","og_image":[{"width":2560,"height":1709,"url":"https:\/\/frezzapartners.com\/wp-content\/uploads\/2021\/05\/pexels-chokniti-khongchum-3082451-scaled.jpg","type":"image\/jpeg"}],"author":"Frezza Partners","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Frezza Partners","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/frezzapartners.com\/oncologia-relay-therapeutics-accoglie-un-ex-manager-astrazeneca\/#article","isPartOf":{"@id":"https:\/\/frezzapartners.com\/oncologia-relay-therapeutics-accoglie-un-ex-manager-astrazeneca\/"},"author":{"name":"Frezza Partners","@id":"https:\/\/frezzapartners.com\/#\/schema\/person\/b953d1492c9f06a9923aed3b3cbe9fc0"},"headline":"Oncologia, in Relay Therapeutics arriva un ex manager AstraZeneca","datePublished":"2021-05-05T10:18:06+00:00","dateModified":"2021-05-05T10:18:41+00:00","mainEntityOfPage":{"@id":"https:\/\/frezzapartners.com\/oncologia-relay-therapeutics-accoglie-un-ex-manager-astrazeneca\/"},"wordCount":250,"image":{"@id":"https:\/\/frezzapartners.com\/oncologia-relay-therapeutics-accoglie-un-ex-manager-astrazeneca\/#primaryimage"},"thumbnailUrl":"https:\/\/frezzapartners.com\/wp-content\/uploads\/2021\/05\/pexels-chokniti-khongchum-3082451-scaled.jpg","keywords":["astrazeneca","relay therapeutics"],"articleSection":["News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/frezzapartners.com\/oncologia-relay-therapeutics-accoglie-un-ex-manager-astrazeneca\/","url":"https:\/\/frezzapartners.com\/oncologia-relay-therapeutics-accoglie-un-ex-manager-astrazeneca\/","name":"Oncologia, in Relay Therapeutics arriva un ex manager AstraZeneca - Frezza Partners","isPartOf":{"@id":"https:\/\/frezzapartners.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/frezzapartners.com\/oncologia-relay-therapeutics-accoglie-un-ex-manager-astrazeneca\/#primaryimage"},"image":{"@id":"https:\/\/frezzapartners.com\/oncologia-relay-therapeutics-accoglie-un-ex-manager-astrazeneca\/#primaryimage"},"thumbnailUrl":"https:\/\/frezzapartners.com\/wp-content\/uploads\/2021\/05\/pexels-chokniti-khongchum-3082451-scaled.jpg","datePublished":"2021-05-05T10:18:06+00:00","dateModified":"2021-05-05T10:18:41+00:00","author":{"@id":"https:\/\/frezzapartners.com\/#\/schema\/person\/b953d1492c9f06a9923aed3b3cbe9fc0"},"breadcrumb":{"@id":"https:\/\/frezzapartners.com\/oncologia-relay-therapeutics-accoglie-un-ex-manager-astrazeneca\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/frezzapartners.com\/oncologia-relay-therapeutics-accoglie-un-ex-manager-astrazeneca\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/frezzapartners.com\/oncologia-relay-therapeutics-accoglie-un-ex-manager-astrazeneca\/#primaryimage","url":"https:\/\/frezzapartners.com\/wp-content\/uploads\/2021\/05\/pexels-chokniti-khongchum-3082451-scaled.jpg","contentUrl":"https:\/\/frezzapartners.com\/wp-content\/uploads\/2021\/05\/pexels-chokniti-khongchum-3082451-scaled.jpg","width":2560,"height":1709},{"@type":"BreadcrumbList","@id":"https:\/\/frezzapartners.com\/oncologia-relay-therapeutics-accoglie-un-ex-manager-astrazeneca\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/frezzapartners.com\/"},{"@type":"ListItem","position":2,"name":"Oncologia, in Relay Therapeutics arriva un ex manager AstraZeneca"}]},{"@type":"WebSite","@id":"https:\/\/frezzapartners.com\/#website","url":"https:\/\/frezzapartners.com\/","name":"Frezza Partners","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/frezzapartners.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/frezzapartners.com\/#\/schema\/person\/b953d1492c9f06a9923aed3b3cbe9fc0","name":"Frezza Partners","url":"https:\/\/frezzapartners.com\/en\/author\/fr3zz4partn3rs\/"}]}},"_links":{"self":[{"href":"https:\/\/frezzapartners.com\/en\/wp-json\/wp\/v2\/posts\/1099309","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/frezzapartners.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/frezzapartners.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/frezzapartners.com\/en\/wp-json\/wp\/v2\/users\/297440"}],"replies":[{"embeddable":true,"href":"https:\/\/frezzapartners.com\/en\/wp-json\/wp\/v2\/comments?post=1099309"}],"version-history":[{"count":0,"href":"https:\/\/frezzapartners.com\/en\/wp-json\/wp\/v2\/posts\/1099309\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/frezzapartners.com\/en\/wp-json\/wp\/v2\/media\/1099310"}],"wp:attachment":[{"href":"https:\/\/frezzapartners.com\/en\/wp-json\/wp\/v2\/media?parent=1099309"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/frezzapartners.com\/en\/wp-json\/wp\/v2\/categories?post=1099309"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/frezzapartners.com\/en\/wp-json\/wp\/v2\/tags?post=1099309"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}